ライブ
FierceBiotechVedana Therapeutics surfaces with $46M to develop next generation of migraine prevention therapiesFierceBiotechUniQure stock surges after FDA U-turn clears path to gene therapy filingPharmaVoiceWhy ivermectin is in the limelight againClinical OMICsPhilippe Pouletty: Turning Europe’s Life Science Startups Into World LeadersBioWorldLundbeck patents new orexin OX2 receptor agonistsBioWorldZealand Pharma reports IL-23R antagonistsBioWorldChengdu Chipscreen Pharmaceutical synthesizes new MOGAT2 inhibitorsBioWorldPRMT5 inhibitors reported in Prospect Therapeutics patentBioWorldIgnis Therapeutics discloses new dopamine D1 receptor PAMsLabiotechEight in vivo CAR T biotechs to follow closelyFierceBiotech'Biopharma ecosystem is back to full health,' fueled by M&A: PwCFierceBiotechJazz, AbCellera strike TCE discovery and development deal worth up to $792M per drug

アーカイブ

最新 古い順 クリア
@Guangdong Guanghua Sci-Tech Co.,Ltd.
合計 12
情報源 Guangdong Guanghua Sci-Tech Co.,Ltd.
検索 --